| |
|
| Investors |
| » |
Venrock |
| » |
Investcorp Technology Ventures |
| » |
Investor Growth Capital |
| » |
Partner Ventures |
| |
 Venrock
Venrock is a premier venture capital firm with offices in Menlo Park, New York, Cambridge, MA, and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues a seven-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. Having invested $1.9 billion in 400 companies resulting in over 120 IPOs over the past 38 years, Venrock's investment returns place it among the top tier venture capital firms that have achieved consistently superior performance. With a primary focus on technology, healthcare, and energy, portfolio companies have included Apple Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna Therapeutics, and StrataCom. |
| |
 Investcorp Technology Ventures
Based in New York and London, Investcorp Technology Ventures invests in technology-driven companies with established products, a growing revenue base and profitability, or a path to profitability. It is focused on venture buyout, corporate spinout and growth capital financing transactions of $10 million to $25 million in technology companies in North America and Europe. Currently, Investcorp Technology Ventures manages more than $500 million in two funds. Investcorp Technology Ventures is part of Investcorp, a global investment group with offices in New York, London and Bahrain. In addition to Investcorp Technology Ventures, the firm has three other lines of business: private equity, real estate investment and hedge funds. It was established in 1982 and currently has more than $9 billion of assets under management in alternative investments. |
| |
 Investor Growth Capital
Investor Growth Capital (IGC) is the wholly-owned venture capital arm of Investor AB, a publicly traded industrial holding company, listed on the Stockholm Exchange with a market capitalization of $20 billion. IGC was formed in the mid-1990s to invest in high quality, growth oriented companies, primarily in the IT and Healthcare industries. Today its 30 investment professionals are developing a portfolio whose value exceeds $850 million from offices located in New York, Menlo Park, Stockholm, Hong Kong, Tokyo and Beijing. Investor AB is a leading shareholder in a number of European multinational corporations, including Astra Zeneca, Ericsson, Atlas Copco and SEB. For almost a century Investor AB's business philosophy has been to build best-in-class companies in sectors where the group has strong knowledge and a networking advantage. IGC shares that approach and benefits from Investor AB's extensive global network of companies and senior managers. |
| |
 Partner Ventures
Partner Ventures is an investment fund that purchases preferred stock in excellent companies and works with those companies to achieve long-term, strategic and financial objectives. We focus on acquiring material positions in individual, late stage, emerging growth companies. Partner Ventures prides itself in being a Value Added Partner in all of its transactions, and has a reputation of working effectively with company management and their boards. |
|
|
|
|
